GR3034991T3 - Dihydrobenzofuranes - Google Patents
DihydrobenzofuranesInfo
- Publication number
- GR3034991T3 GR3034991T3 GR20000402680T GR20000402680T GR3034991T3 GR 3034991 T3 GR3034991 T3 GR 3034991T3 GR 20000402680 T GR20000402680 T GR 20000402680T GR 20000402680 T GR20000402680 T GR 20000402680T GR 3034991 T3 GR3034991 T3 GR 3034991T3
- Authority
- GR
- Greece
- Prior art keywords
- pct
- sec
- date
- pub
- dihydrobenzofuranes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH232394 | 1994-07-22 | ||
PCT/EP1995/002841 WO1996003399A1 (de) | 1994-07-22 | 1995-07-19 | Dihydrobenzofurane |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3034991T3 true GR3034991T3 (en) | 2001-03-30 |
Family
ID=4231132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20000402680T GR3034991T3 (en) | 1994-07-22 | 2000-12-05 | Dihydrobenzofuranes |
Country Status (22)
Country | Link |
---|---|
US (1) | US6121274A (el) |
EP (1) | EP0772610B9 (el) |
JP (1) | JP4146894B2 (el) |
KR (1) | KR100381584B1 (el) |
CN (1) | CN1068879C (el) |
AT (1) | ATE196765T1 (el) |
AU (1) | AU702346B2 (el) |
CZ (1) | CZ291758B6 (el) |
DE (1) | DE59508773D1 (el) |
DK (1) | DK0772610T3 (el) |
ES (1) | ES2152414T3 (el) |
FI (1) | FI970246A0 (el) |
GR (1) | GR3034991T3 (el) |
HU (1) | HU221504B (el) |
MX (1) | MX9700557A (el) |
NO (1) | NO311221B1 (el) |
NZ (1) | NZ290420A (el) |
PL (1) | PL185683B1 (el) |
PT (1) | PT772610E (el) |
RU (1) | RU2138498C1 (el) |
SK (1) | SK281857B6 (el) |
WO (1) | WO1996003399A1 (el) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6514996B2 (en) | 1995-05-19 | 2003-02-04 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of benzofuran or benzodioxole |
ES2258775T3 (es) * | 1995-05-19 | 2006-09-01 | Kyowa Hakko Kogyo Co., Ltd. | Compuestos heterociclicos que contienen oxigeno. |
HUP9903797A3 (en) * | 1995-12-05 | 2001-08-28 | Darwin Discovery Ltd Milton Ro | Benzofuran carboxamides and sulphonamides, their use for producing medicaments and such medicaments |
ES2187775T3 (es) * | 1996-05-15 | 2003-06-16 | Altana Pharma Ag | Imidazopiridinas. |
WO1997044337A1 (en) * | 1996-05-20 | 1997-11-27 | Darwin Discovery Limited | Benzofuran carboxamides and their therapeutic use |
DE19628622A1 (de) * | 1996-07-16 | 1998-01-22 | Byk Gulden Lomberg Chem Fab | Neue 5-substituierte [2H] Chromene |
DE19628621A1 (de) * | 1996-07-16 | 1998-01-22 | Byk Gulden Lomberg Chem Fab | Neue 4-substituierte Benzofurane |
ATE229516T1 (de) * | 1996-08-19 | 2002-12-15 | Altana Pharma Ag | Benzofuran-4-carboxamide |
AU5652698A (en) * | 1996-11-12 | 1998-06-03 | Byk Gulden Lomberg Chemische Fabrik Gmbh | (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors |
EP0941221B1 (en) * | 1996-11-20 | 2003-02-26 | ALTANA Pharma AG | Substituted dihydrobenzofurans as pde inhibitors |
EP1042319B1 (en) * | 1997-12-15 | 2004-02-04 | ALTANA Pharma AG | Dihydrobenzofurans |
GB2333041A (en) * | 1998-01-13 | 1999-07-14 | Johnson & Johnson Medical Ltd | Wound Composition |
AU758194C (en) | 1998-05-05 | 2004-04-08 | Altana Pharma Ag | Novel benzimidazoles and benzoxazoles |
CA2334979A1 (en) * | 1998-06-10 | 1999-12-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
EA006685B1 (ru) | 1999-08-21 | 2006-02-24 | Алтана Фарма Аг | Синергетическая композиция |
GB0003257D0 (en) | 2000-02-11 | 2000-04-05 | Darwin Discovery Ltd | Heterocyclic compounds and their therapeutic use |
CN1646118A (zh) * | 2002-03-29 | 2005-07-27 | 中外制药株式会社 | 预防或治疗呼吸系统疾病的药物组合物 |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
RU2384579C2 (ru) * | 2005-11-04 | 2010-03-20 | Ниппон Сода Ко., Лтд. | Орто-замещенное производное анилина и антиоксидантное лекарственное средство |
US7842713B2 (en) * | 2006-04-20 | 2010-11-30 | Pfizer Inc | Fused phenyl amido heterocyclic compounds |
NZ581547A (en) | 2007-05-16 | 2012-02-24 | Nycomed Gmbh | Pyrazolone derivatives as phosphodiesterase type 4 inhibitors |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
EP2321341B1 (en) | 2008-07-16 | 2017-02-22 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
EP2344458A1 (en) | 2008-09-11 | 2011-07-20 | Pfizer Inc. | Heteroaryls amide derivatives and their use as glucokinase activators |
BRPI1013246B1 (pt) * | 2009-03-11 | 2019-10-01 | Pfizer, Inc. | Derivados de benzofuranila, suas composições farmacêuticas e seus usos |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
MX357121B (es) | 2011-03-01 | 2018-06-27 | Synergy Pharmaceuticals Inc Star | Proceso de preparacion de agonistas c de guanilato ciclasa. |
BR112014016648B1 (pt) * | 2012-01-12 | 2020-10-27 | Shanghai Hengrui Pharmaceutical Co., Ltd. | derivados policíclicos, seus usos e seu processo de preparação, e composição farmacêutica |
CA2902348C (en) | 2013-02-25 | 2021-11-30 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
BR112015030326A2 (pt) | 2013-06-05 | 2017-08-29 | Synergy Pharmaceuticals Inc | Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos |
WO2015021358A2 (en) | 2013-08-09 | 2015-02-12 | Dominique Charmot | Compounds and methods for inhibiting phosphate transport |
TWI713530B (zh) | 2015-06-05 | 2020-12-21 | 美商艾佛艾姆希公司 | 作為除草劑之嘧啶氧基苯衍生物 |
US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE71647B1 (en) * | 1991-01-28 | 1997-02-26 | Rhone Poulenc Rorer Ltd | Benzamide derivatives |
AU670949B2 (en) * | 1992-06-15 | 1996-08-08 | Celltech Limited | Trisubstituted phenyl derivatives as selective phosphodiesterase IV inhibitors |
GB9212693D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
-
1995
- 1995-07-19 JP JP50543996A patent/JP4146894B2/ja not_active Expired - Lifetime
- 1995-07-19 ES ES95926953T patent/ES2152414T3/es not_active Expired - Lifetime
- 1995-07-19 WO PCT/EP1995/002841 patent/WO1996003399A1/de active IP Right Grant
- 1995-07-19 DE DE59508773T patent/DE59508773D1/de not_active Expired - Lifetime
- 1995-07-19 RU RU97102828A patent/RU2138498C1/ru not_active IP Right Cessation
- 1995-07-19 CN CN95195177A patent/CN1068879C/zh not_active Expired - Fee Related
- 1995-07-19 EP EP95926953A patent/EP0772610B9/de not_active Expired - Lifetime
- 1995-07-19 SK SK2-97A patent/SK281857B6/sk not_active IP Right Cessation
- 1995-07-19 NZ NZ290420A patent/NZ290420A/xx not_active IP Right Cessation
- 1995-07-19 DK DK95926953T patent/DK0772610T3/da active
- 1995-07-19 KR KR1019970700420A patent/KR100381584B1/ko not_active IP Right Cessation
- 1995-07-19 MX MX9700557A patent/MX9700557A/es not_active IP Right Cessation
- 1995-07-19 US US08/750,920 patent/US6121274A/en not_active Expired - Lifetime
- 1995-07-19 HU HU9700022A patent/HU221504B/hu not_active IP Right Cessation
- 1995-07-19 AT AT95926953T patent/ATE196765T1/de not_active IP Right Cessation
- 1995-07-19 CZ CZ1997188A patent/CZ291758B6/cs not_active IP Right Cessation
- 1995-07-19 PT PT95926953T patent/PT772610E/pt unknown
- 1995-07-19 AU AU31153/95A patent/AU702346B2/en not_active Ceased
- 1995-07-19 PL PL95318297A patent/PL185683B1/pl not_active IP Right Cessation
-
1997
- 1997-01-09 NO NO19970092A patent/NO311221B1/no not_active IP Right Cessation
- 1997-01-21 FI FI970246A patent/FI970246A0/fi unknown
-
2000
- 2000-12-05 GR GR20000402680T patent/GR3034991T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN1068879C (zh) | 2001-07-25 |
PT772610E (pt) | 2001-03-30 |
MX9700557A (es) | 1997-12-31 |
HU9700022D0 (en) | 1997-02-28 |
RU2138498C1 (ru) | 1999-09-27 |
HUT77925A (hu) | 1998-11-30 |
HU221504B (en) | 2002-10-28 |
WO1996003399A1 (de) | 1996-02-08 |
SK281857B6 (sk) | 2001-08-06 |
NZ290420A (en) | 1999-01-28 |
JPH10503484A (ja) | 1998-03-31 |
CZ291758B6 (cs) | 2003-05-14 |
PL318297A1 (en) | 1997-06-09 |
FI970246A (fi) | 1997-01-21 |
KR100381584B1 (ko) | 2003-08-21 |
AU3115395A (en) | 1996-02-22 |
NO311221B1 (no) | 2001-10-29 |
DK0772610T3 (da) | 2001-01-29 |
EP0772610B1 (de) | 2000-10-04 |
ATE196765T1 (de) | 2000-10-15 |
NO970092D0 (no) | 1997-01-09 |
AU702346B2 (en) | 1999-02-18 |
FI970246A0 (fi) | 1997-01-21 |
CN1159804A (zh) | 1997-09-17 |
CZ18897A3 (en) | 1997-09-17 |
ES2152414T3 (es) | 2001-02-01 |
DE59508773D1 (de) | 2000-11-09 |
EP0772610B9 (de) | 2001-07-25 |
NO970092L (no) | 1997-01-09 |
US6121274A (en) | 2000-09-19 |
JP4146894B2 (ja) | 2008-09-10 |
SK297A3 (en) | 1997-08-06 |
EP0772610A1 (de) | 1997-05-14 |
PL185683B1 (pl) | 2003-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3034991T3 (en) | Dihydrobenzofuranes | |
ZA959516B (en) | Use of dioxomorpholines for combating endoparasites new dioxomorpholines and processes for their preparation | |
BG103485A (en) | Ketobanzamides as calpain inhibitors | |
IL114794A0 (en) | Peptidic compounds analogous to distramycin process for their preparation and their use | |
CY2431B1 (en) | Novel phenanthridines substituted in the 6 position. | |
BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
NO970161D0 (no) | Triazolforbindelser og anvendelse derav | |
ES2143666T3 (es) | P-amidinobencilamidas dipeptidicas con restos sulfonilo, o bien aminosulfonilo n-terminales. | |
SI1377574T1 (el) | ||
GR3035744T3 (en) | N-substituted azabicycloheptane derivatives useful as neuroleptics | |
HU9503552D0 (en) | Substituted arylthioalkylthiopyridines | |
ATE207480T1 (de) | Substituierte aminoalkylaminopyridine | |
CA2195663A1 (en) | Dihydrobenzofuranes |